BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangio-carcinoma. J Hepatobiliary Pancreat Surg. 2000;7:148-154. [PMID: 10982607 DOI: 10.1007/s005340050169] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Bold RJ, Goodnight JE. Hilar cholangiocarcinoma: surgical and endoscopic approaches. Surg Clin North Am. 2004;84:525-542. [PMID: 15062660 DOI: 10.1016/s0039-6109(03)00232-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Juntermanns B, Kaiser GM, Reis H, Gries S, Kasper S, Paul A, Canbay A, Fingas CD. Long-term Survival after resection for perihilar cholangiocarcinoma: Impact of UICC staging and surgical procedure. Turk J Gastroenterol 2019;30:454-60. [PMID: 31061000 DOI: 10.5152/tjg.2019.18275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kogure K, Ishizaki M, Nemoto M, Kuwano H, Yorifuji H, Takata K, Ishikawa H, Makuuchi M. Morphogenesis of an anomalous ligamentum venosum terminating in the superior left hepatic vein in a human liver. J Hepatobiliary Pancreat Surg 2005;12:310-3. [PMID: 16133698 DOI: 10.1007/s00534-005-0987-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg. 2002;6:617-624. [PMID: 12127130 DOI: 10.1016/s1091-255x(01)00008-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
5 Vogel A, Wege H, Caca K, Nashan B, Neumann U. The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int. 2014;111:748-754. [PMID: 25412632 DOI: 10.3238/arztebl.2014.0748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
6 Paik KY, Choi DW, Chung JC, Kang KT, Kim SB. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1268-1274. [PMID: 18330655 DOI: 10.1007/s11605-008-0503-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ishihara S, Miyakawa S, Takada T, Takasaki K, Nimura Y, Tanaka M, Miyazaki M, Nagakawa T, Kayahara M, Horiguchi A. Status of surgical treatment of biliary tract cancer. Dig Surg. 2007;24:131-136. [PMID: 17446708 DOI: 10.1159/000101901] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
8 Gumbs AA, Jarufe N, Gayet B. Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg Endosc 2013;27:406-14. [PMID: 22926892 DOI: 10.1007/s00464-012-2489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
9 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
10 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol. 2009;15:4240-4262. [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 147] [Article Influence: 14.4] [Reference Citation Analysis]
11 Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol 2008;25:110-22. [PMID: 21326552 DOI: 10.1055/s-2008-1076684] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
12 Mansfield SD, Barakat O, Charnley RM, Jaques BC, O'Suilleabhain CB, Atherton PJ, Manas D. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 2005;11:7625-30. [PMID: 16437689 DOI: 10.3748/wjg.v11.i48.7625] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
13 Shi Z, Yang MZ, He QL, Ou RW, Chen YT. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma. World J Gastroenterol 2009;15:1892-6. [PMID: 19370789 DOI: 10.3748/wjg.15.1892] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
14 Cherif S, Rais H, Hakmaoui A, Sellami S, Elantri S, Amine A. Linking Helicobacter pylori with gallbladder and biliary tract cancer in Moroccan population using clinical and pathological profiles. Bioinformation 2019;15:735-43. [PMID: 31831956 DOI: 10.6026/97320630015735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210-218. [PMID: 19638920 DOI: 10.1097/sla.0b013e3181afe0ab] [Cited by in Crossref: 153] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
16 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
17 Neuhaus P, Thelen A. Radical surgery for right-sided klatskin tumor. HPB (Oxford). 2008;10:171-173. [PMID: 18773048 DOI: 10.1080/13651820801992708] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
18 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
19 Yam BL, Siegelman ES. MR imaging of the biliary system. Radiol Clin North Am. 2014;52:725-755. [PMID: 24889169 DOI: 10.1016/j.rcl.2014.02.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
20 Juntermanns B, Fingas CD, Sotiropoulos GC, Jaradat D, Dechêne A, Reis H, Kasper S, Paul A, Kaiser GM. [Klatskin tumor: long-term survival following surgery]. Chirurg 2016;87:514-9. [PMID: 27090415 DOI: 10.1007/s00104-016-0169-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
21 Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-247. [PMID: 16858186 DOI: 10.1097/01.sla.0000217605.66519.38] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 10.9] [Reference Citation Analysis]
22 Neumann UP, Schmeding M. Role of surgery in cholangiocarcinoma: From resection to transplantation. Best Pract Res Clin Gastroenterol. 2015;29:295-308. [PMID: 25966429 DOI: 10.1016/j.bpg.2015.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
23 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med. 2012;79:232-245. [PMID: 22499494 DOI: 10.1002/msj.21298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
25 Malago M, Frilling A, Li J, Lang H, Broelsch CE. Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford). 2008;10:179-182. [PMID: 18773050 DOI: 10.1080/13651820801992500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
26 Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202:310-320. [PMID: 21871986 DOI: 10.1016/j.amjsurg.2010.08.041] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
27 Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
28 Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Sekido H, Togo S. Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer? Langenbecks Arch Surg 2003;388:33-41. [DOI: 10.1007/s00423-003-0358-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
29 IJitsma AJ, Appeltans BM, de Jong KP, Porte RJ, Peeters PM, Slooff MJ. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg. 2004;8:686-694. [PMID: 15358329 DOI: 10.1016/j.gassur.2004.04.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kobayashi S, Nagano H, Marubashi S, Takeda Y, Tanemura M, Konishi K, Yoshioka Y, Inoue T, Doki Y, Mori M. Impact of postoperative irradiation after non-curative resection of hilar biliary cancer. J Surg Oncol. 2009;100:657-662. [PMID: 19798692 DOI: 10.1002/jso.21409] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
31 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
32 Ferrero A, Russolillo N, Viganò L, Sgotto E, Lo Tesoriere R, Amisano M, Capussotti L. Safety of conservative management of bile leakage after hepatectomy with biliary reconstruction. J Gastrointest Surg. 2008;12:2204-2211. [PMID: 18642049 DOI: 10.1007/s11605-008-0586-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
33 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
34 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 19.8] [Reference Citation Analysis]
35 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 19.4] [Reference Citation Analysis]
36 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
37 Malhi H, Gores GJ. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther. 2006;23:1287-1296. [PMID: 16629933 DOI: 10.1111/j.1365-2036.2006.02900.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
38 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
39 Tan JW, Hu BS, Chu YJ, Tan YC, Ji X, Chen K, Ding XM, Zhang A, Chen F, Dong JH. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg 2013;37:614-21. [PMID: 23283218 DOI: 10.1007/s00268-012-1878-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
40 Silva MA, Tekin K, Aytekin F, Bramhall SR, Buckels JA, Mirza DF. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol. 2005;31:533-539. [PMID: 15922889 DOI: 10.1016/j.ejso.2005.02.021] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
41 Matos C, Serrao E, Bali MA. Magnetic resonance imaging of biliary tumors. Magn Reson Imaging Clin N Am. 2010;18:477-496. [PMID: 21094451 DOI: 10.1016/j.mric.2010.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
42 Yang M, Li WW, Chen JH, Cui MH, Liu JL. The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis. Medicine (Baltimore) 2021;100:e24727. [PMID: 33607815 DOI: 10.1097/MD.0000000000024727] [Reference Citation Analysis]
43 Hernandez J, Cowgill SM, Al-saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A. An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection. Ann Surg Oncol 2008;15:807-14. [DOI: 10.1245/s10434-007-9756-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
44 Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208:134-147. [PMID: 19228515 DOI: 10.1016/j.jamcollsurg.2008.09.007] [Cited by in Crossref: 148] [Cited by in F6Publishing: 134] [Article Influence: 11.4] [Reference Citation Analysis]
45 Taniguchi K, Tabata M, Iida T, Hori T, Yagi S, Uemoto S. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 2006;32:208-12. [PMID: 16377119 DOI: 10.1016/j.ejso.2005.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
46 Nagorney DM, Kendrick ML. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg. 2006;40:159-171. [PMID: 17163100 DOI: 10.1016/j.yasu.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
47 Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D’Angelica M, Fong Y. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11:445-451. [PMID: 19768150 DOI: 10.1111/j.1477-2574.2009.00090.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
48 Sarmiento JM, Nagorney DM. Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surgical Oncology Clinics of North America 2002;11:893-908. [DOI: 10.1016/s1055-3207(02)00034-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
49 Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329-337. [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
50 Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101. [PMID: 15213624 DOI: 10.1097/01.sla.0000129491.43855.6b] [Cited by in Crossref: 219] [Cited by in F6Publishing: 185] [Article Influence: 12.9] [Reference Citation Analysis]
51 Kogure K, Ishizaki M, Nemoto M, Kuwano H, Yorifuji H, Ishikawa H, Takata K, Makuuchi M. Close relation between the inferior vena cava ligament and the caudate lobe in the human liver. J Hepatobiliary Pancreat Surg 2007;14:297-301. [PMID: 17520206 DOI: 10.1007/s00534-006-1148-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]